tradingkey.logo
tradingkey.logo
Search

Caris Life Sciences Inc

CAI
Add to Watchlist
15.670USD
-0.420-2.61%
Close 07-31 16:00ETQuotes delayed by 15 min
4.43BMarket Cap
LossP/E TTM

Caris Life Sciences Inc

15.670
-0.420-2.61%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.61%

5 Days

+0.97%

1 Month

-16.43%

6 Months

-32.34%

Year to Date

-41.92%

1 Year

-44.12%

Key Figures
16.050Open
16.140High
3.51MVolume
LossP/E TTM
42.70P/E Dynamic
--Dividend TTM
1.24%Turnover Ratio
16.090Prev. Close
15.230Low
40.82MTurnover
LossP/E Static
7.67P/B
0.00%Div Yield TTM
4.67%ROA
42.50052wk High
0.85Volume Ratio
-378.26MNet Profit
282.53MShares
-2.7620EPS TTM
--Beta
--ROE
16.28052wk Low
5.66%Amplitude
65.39%Gross Margin
4.43BMarket Cap
-2.59Reward/Risk
3.73%Risk Rate

Key Insights

Caris Life Sciences Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 83 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 27.92.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Caris Life Sciences Inc's Score

Industry at a Glance

Industry Ranking
83 / 199
Overall Ranking
169 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Caris Life Sciences Inc Highlights

StrengthsRisks
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 165.26% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 812.03M.
Fairly Valued
The company’s latest PE is -5.67, at a medium 3-year percentile range.
Held by Stanley Druckenmiller
Star Investor Stanley Druckenmiller holds 2.20M shares of this stock.

Analyst Rating

Based on 12 analysts
Buy
Current Rating
27.917
Target Price
+79.07%
Upside Space

Caris Life Sciences Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 12 analysts
Buy
Current Rating
27.917
Target Price
+79.07%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Caris Life Sciences Inc
CAI
12
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22

Indicators

Indicators
Sell(4)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.089
Sell
RSI(14)
41.427
Neutral
STOCH(KDJ)(9,3,3)
49.173
Buy
ATR(14)
0.826
High Vlolatility
CCI(14)
-46.472
Neutral
Williams %R
79.562
Sell
TRIX(12,20)
-0.528
Sell
StochRSI(14)
38.437
Sell
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
15.714
Sell
MA10
15.641
Buy
MA20
16.415
Sell
MA50
16.884
Sell
MA100
17.685
Sell
MA200
21.649
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Caris Life Sciences Inc Info

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Ticker SymbolCAI
CompanyCaris Life Sciences Inc
CEOHalbert (David Dean)
Websitehttps://www.carislifesciences.com/

Shareholders

Shareholders
Shareholders
Proportion
Halbert (David D)
43.52%
Sixth Street Partners, LLC
6.86%
J.H. Whitney Capital Partners, LLC
6.46%
J. H. Whitney Equity Partners VI, LLC
6.46%
Fidelity Management & Research Company LLC
4.48%
Other
32.23%

FAQs

What is the current price of Caris Life Sciences Inc (CAI)?

The current price of Caris Life Sciences Inc (CAI) is 15.67.

What is the symbol of Caris Life Sciences Inc?

The ticker symbol of Caris Life Sciences Inc is CAI.

What is the 52-week high of Caris Life Sciences Inc?

The 52-week high of Caris Life Sciences Inc is 42.50.

What is the 52-week low of Caris Life Sciences Inc?

The 52-week low of Caris Life Sciences Inc is 16.28.

What is the market capitalization of Caris Life Sciences Inc?

The market capitalization of Caris Life Sciences Inc is 4.43B.

Is Caris Life Sciences Inc (CAI) currently rated as Buy, Hold, or Sell?

According to analysts, Caris Life Sciences Inc (CAI) has an overall rating of Buy, with a price target of 27.92.

What is the Earnings Per Share (EPS TTM) of Caris Life Sciences Inc (CAI)?

The Earnings Per Share (EPS TTM) of Caris Life Sciences Inc (CAI) is -3.22.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.